CAMBRIDGE, MASS. — Boston-based Colliers Meredith & Grew (CMG) has brokered the sale of a 148,116-square-foot biotechnology portfolio located in the Cambridgeport neighborhood of Cambridge for $90.5 million. The portfolio consists of four properties: a 48,000-square-foot building located at 185 Albany St.; a 48,000-square-foot property located at 195 Albany St.; a 37,116-square-foot property located at 149 Sidney St.; and a 15,000-square-foot building located at 148 Sidney St. The properties are all fully occupied by four tenants: the Massachusetts Institute of Technology (MIT), Cubist Pharmaceuticals, Shire Pharmaceuticals, and Acceleron Pharma. Lisa Campoli, Joe Flaherty, Tom Hynes and Nick Herz of CMG represented the seller, a private family trust, and procured the buyer, MIT.
113
previous post